BioSpace News Archive

Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 second quarter which ended on March 31, 2021 on Monday, May 10, 2021 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, May 10, 2021 at 4:30 p.m. Eastern Time

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 first quarter financial results on Tuesday, May 4, 2021 after the close of the financial markets. Company management will host a live audio webcast at 4:30 p.m. ET / 9:30 p.m. IST to discuss first quarter 2021 financial results

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S. FDA safety communication on the differences in complication rates between acellular dermal matrix (ADM) products used in implant-based breast reconstruction.

hear.com, the largest online provider of expert, medical-grade hearing care globally, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of the common shares of hear.com N.V.

Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) (“Brooklyn” or “the Company”), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today announced that on 16 April 2021, Dr. Federoff was granted a nonqualified stock option covering 2,627,915 shares of Brooklyn’s common stock (the “Time-Based Option”).

MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the first quarter of 2021 after the market closes on Thursday, April 29, 2021.

R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of David Dill, president and chief executive officer of LifePoint Health, to the company’s board of directors, effective April 18, 2021

eQcell Inc. Canada’s premier clinical-stage regenerative medicine company addressing conditions and diseases affecting sporting and domestic animals globally, announces the appointment to its Board of Directors of Dr. C. Wayne McIlwraith.

National Advisory Committee on Immunization members and federal and provincial government officials will provide a technical briefing for media on NACI’s evidence summary update for the AstraZeneca COVID-19 vaccine.

The Biden Administration announced Friday a $1.7 billion investment to monitor new and emerging COVID-19 variants which could induce another pandemic wave.